Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, today announces that DBLG2 ...

With the prevalence of diabetes quadrupling in recent decades and currently impacting more than 500 million people in the world, it is no surprise that the technology for insulin delivery has also ...

ORLANDO -- For type 1 diabetes patients, switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza) maintained glycemic control -- for those who used it as intended, the ...

Most of the 38 million people living with diabetes in the U.S. use daily injections or insulin pumps to keep glucose at safe levels — but new research suggests that a third option could be just as ...

Home or hospital insulin pumps are safe and improve glucose control in pediatric, adolescent, and young adult patients with type 1 diabetes hospitalized for noncritical illness. "Safety is not ...

Last week the FDA granted its first marketing authorization to an interoperable insulin pump that is compatible with automated insulin dosing systems, continuous glucose monitors, blood glucose meters ...

Continuous insulin infusion delivered by a portable infusion pump allows young people with type 1 diabetes (insulin-dependent diabetes) to maintain better control of their blood sugar levels than is ...

Tandem Diabetes Care (TNDM) announced on Friday that the European Union has issued the CE mark, expanding the indications for its automated insulin delivery systems, t:slim X2 and Tandem Mobi in ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A medical device manufacturer has ...